Poseida Therapeutics, Inc. Shares Authorized
Poseida Therapeutics, Inc. had Shares Authorized of 250.00 million shares as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2024-11-07
- 2024-09-30: Common Stock, Shares Authorized 250.00M shares.
- 2024-06-30: Common Stock, Shares Authorized 250.00M shares.
- 2024-03-31: Common Stock, Shares Authorized 250.00M shares.
- 2023-12-31: Common Stock, Shares Authorized 250.00M shares.
| Period end | Common Stock, Shares Authorized |
|---|---|
| 2024-09-30 | 250.00M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 250.00M shares 10-Q · filed 2024-08-05 |
| 2024-03-31 | 250.00M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 250.00M shares 10-Q · filed 2024-11-07 |
| 2023-09-30 | 250.00M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 250.00M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 250.00M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 250.00M shares 10-K · filed 2024-03-07 |
| 2022-09-30 | 250.00M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 250.00M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 250.00M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 250.00M shares 10-K · filed 2023-03-09 |
| 2021-09-30 | 250.00M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 250.00M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 250.00M shares 10-Q · filed 2021-05-11 |
| 2020-12-31 | 250.00M shares 10-K · filed 2022-03-10 |
| 2020-09-30 | 250.00M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 73.00M shares 10-Q · filed 2020-08-20 |
| 2019-12-31 | 57.01M shares 10-K · filed 2021-03-11 |